These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9040721)

  • 21. Tetrabenazine treatment for Huntington's disease-associated chorea.
    Ondo WG; Tintner R; Thomas M; Jankovic J
    Clin Neuropharmacol; 2002; 25(6):300-2. PubMed ID: 12469001
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tetrabenazine and movement disorders.
    Asher SW; Aminoff MJ
    Neurology; 1981 Aug; 31(8):1051-4. PubMed ID: 6455607
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tetrabenazine in the treatment of Huntington's disease.
    Paleacu D
    Neuropsychiatr Dis Treat; 2007; 3(5):545-51. PubMed ID: 19381278
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tetrabenazine in the treatment of severe pediatric chorea.
    Chatterjee A; Frucht SJ
    Mov Disord; 2003 Jun; 18(6):703-6. PubMed ID: 12784277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tetrabenazine for involuntary movement disorders.
    Kingston D
    Med J Aust; 1979 Jun; 1(13):628-30. PubMed ID: 158700
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive tremor.
    Stacy M; Jankovic J
    Mov Disord; 1992; 7(1):53-7. PubMed ID: 1348352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of tetrabenazine on tics and sleep of Gilles de la Tourette's syndrome.
    Jankovic J; Glaze DG; Frost JD
    Neurology; 1984 May; 34(5):688-92. PubMed ID: 6584743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Valbenazine granted breakthrough drug status for treating tardive dyskinesia.
    Müller T
    Expert Opin Investig Drugs; 2015 Jun; 24(6):737-42. PubMed ID: 25809133
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictive factors for tolerability of tetrabenazine in patients with hyperkinetic movement disorders.
    Sahin T; Yilmaz R; Akbostanci MC
    Parkinsonism Relat Disord; 2020 May; 74():36-37. PubMed ID: 32311641
    [No Abstract]   [Full Text] [Related]  

  • 30. Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders.
    Toglia JU; McGlamery M; Sambandham RR
    J Clin Psychiatry; 1978 Jan; 39(1):81-7. PubMed ID: 147268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tardive stereotypy and other movement disorders in tardive dyskinesias.
    Stacy M; Cardoso F; Jankovic J
    Neurology; 1993 May; 43(5):937-41. PubMed ID: 8492949
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is history of depression a contraindication to treatment with tetrabenazine?
    Kenney C; Hunter C; Mejia N; Jankovic J
    Clin Neuropharmacol; 2006; 29(5):259-64. PubMed ID: 16960470
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tetrabenazine in the treatment of hyperkinetic movement disorders.
    Jankovic J
    Adv Neurol; 1983; 37():277-89. PubMed ID: 6574695
    [No Abstract]   [Full Text] [Related]  

  • 34. Tetrabenazine in treatment of hyperkinetic movement disorders: an observational study.
    Miguel R; Mendonça MD; Barbosa R; Ladeira F; Lampreia T; Vale J; Bugalho P
    Ther Adv Neurol Disord; 2017 Feb; 10(2):81-90. PubMed ID: 28382107
    [TBL] [Abstract][Full Text] [Related]  

  • 35. VMAT2 Inhibitors in Neuropsychiatric Disorders.
    Tarakad A; Jimenez-Shahed J
    CNS Drugs; 2018 Dec; 32(12):1131-1144. PubMed ID: 30306450
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tetrabenazine for the treatment of tardive dyskinesia.
    Leung JG; Breden EL
    Ann Pharmacother; 2011 Apr; 45(4):525-31. PubMed ID: 21487088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia caused by tetrabenazine.
    LeWitt PA
    Clin Neuropharmacol; 2013; 36(3):92-3. PubMed ID: 23673911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of involuntary movement disorders with tetrabenazine.
    Swash M; Roberts AH; Zakko H; Heathfield KW
    J Neurol Neurosurg Psychiatry; 1972 Apr; 35(2):186-91. PubMed ID: 4260957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tetrabenazine: Spotlight on Drug Review.
    Kaur N; Kumar P; Jamwal S; Deshmukh R; Gauttam V
    Ann Neurosci; 2016 Sep; 23(3):176-185. PubMed ID: 27721587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of tardive dyskinesia. I. Clinical efficacy of a dopamine-depleting agent, tetrabenazine.
    Kazamatsuri H; Chien C; Cole JO
    Arch Gen Psychiatry; 1972 Jul; 27(1):95-9. PubMed ID: 4555831
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.